Exelixis
EXEL
#1855
Rank
C$15.15 B
Marketcap
C$56.30
Share price
-2.18%
Change (1 day)
15.41%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Earnings for Exelixis (EXEL)

Earnings in 2025 (TTM): C$1.22 Billion

According to Exelixis's latest financial reports the company's current earnings are C$2.28 Billion. In 2024 the company made an earning of C$0.92 Billion, an increase over its 2023 earnings that were of C$0.35 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exelixis from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$1.22 B32.13%
2024 C$0.92 B164.69%
2023 C$0.35 B9.89%
2022 C$0.31 B-20.33%
2021 C$0.40 B124.82%
2020 C$0.17 B-67.14%
2019 C$0.54 B-11.94%
2018 C$0.61 B185.09%
2017 C$0.21 B-325.82%
2016 -C$95.6 Million-58.12%
2015 -C$0.23 Billion-37.61%
2014 -C$0.37 Billion9.75%
2013 -C$0.34 Billion65.96%
2012 -C$0.21 Billion-291.63%
2011 C$0.10 B-195.59%
2010 -C$0.11 Billion-42.17%
2009 -C$0.19 Billion-18.98%
2008 -C$0.24 Billion-6.99%
2007 -C$0.26 Billion46.3%
2006 -C$0.18 Billion33.25%
2005 -C$0.13 Billion-30.92%
2004 -C$0.19 Billion44.29%
2003 -C$0.13 Billion12.86%
2002 -C$0.12 Billion22.79%
2001 -C$93.45 Million60.14%
2000 -C$58.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$44.10 B 3,609.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.13 B 1,257.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$11.22 B 844.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$12.38 B 942.07%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$31.43 B 2,544.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$10.93 B 819.85%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$12.69 B 967.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-C$44.33 Million-103.73%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-C$39.54 Million-103.33%๐Ÿ‡บ๐Ÿ‡ธ USA